Results 101 to 110 of about 13,569 (208)

Primary Coronary Angioplasty in the Elderly [PDF]

open access: yes, 2005
Introdução: A angioplastia primária é a terapêutica de reperfusão com melhores resultados no enfarte agudo do miocárdio (EAM). Este facto assume particular relevância na população acima dos 75 anos, em que o risco hemorrágico relacionado com a trombólise
Cacela, D   +8 more
core  

Cerebrovascular disease - Advances in management [PDF]

open access: yes, 2001
Recent advances in the diagnosis and treatment of stroke have justified its management as a medical emergency. This article summarises current recommendations for the initial management of major types of stroke with emphasis on acute therapy for ...
Cheung, RTF
core  

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel or both?

open access: yesVascular Health and Risk Management, 2006
Matthew A Silva1, Jennifer L Donovan1,3, Pritesh J Gandhi2, Gregory A Volturo31Massachusetts College of Pharmacy and Health Sciences, Department of Pharmacy Practice, Worcester, MA, USA; 2Alexion Pharmaceuticals, Inc., Cheshire, CT, USA; 3UMass Memorial ...
Matthew A Silva   +3 more
doaj  

Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia.

open access: yesAnnals of Thoracic Surgery, 2018
Chia-Ling Lee   +12 more
semanticscholar   +1 more source

Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction [PDF]

open access: yes, 2017
Aims To compare the efficacy and safety of drug-eluting stents vs. bare-metal stents in patients with acute ST-segment elevation myocardial infarction.
Di Lorenzo, Emilio   +19 more
core  

Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients.

open access: yesBritish Journal of Clinical Pharmacology, 2016
J. Siller-Matula   +8 more
semanticscholar   +1 more source

Antiagregación y anticoagulación en síndromes coronarios agudos: niveles de evidencia [PDF]

open access: yes, 2007
Management of acute coronary syndromes (ACS) has moved rapidly in parallel with our understanding of the pathophysiological basis of the disease. In the eighties, the demonstration of the pivotal role of coronary thrombosis in the etiology of a ACS led ...
Garcia, R. (R.)   +3 more
core  

Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease: A meta-analysis of randomized controlled trials [PDF]

open access: yes, 2017
Aims To evaluate whether stents as compared to balloon angioplasty reduce mortality in patients with non-acute coronary artery disease. Methods and results We identified randomized controlled trials comparing stents to balloon angioplasty for the ...
Bucher, Heiner C.   +5 more
core  

Los inhibidores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos. The IIb/IIIa platelet receptor inhibitors in the acute coronary syndromes.

open access: yesRevista Cubana de Cardiología y Cirugía Cardiovascular, 2001
Los inhibidores de los receptores IIb/IIIa, un nuevo grupo de antiagregantes plaquetarios, son potentes bloqueadores del receptor que media la agregación plaquetaria y de ese modo bloquean la vía final común de la formación del trombo plaquetario.
Fidel Manuel Cáceres Lóriga   +1 more
doaj  

Abciximab-induced acute profound thrombocytopenia postpercutaneous coronary intervention

open access: yesBMJ Case Reports, 2017
Todd Golden   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy